1-218406643-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001135599.4(TGFB2):​c.594+1311A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.344 in 151,942 control chromosomes in the GnomAD database, including 10,510 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 10510 hom., cov: 32)

Consequence

TGFB2
NM_001135599.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.459

Publications

17 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.649 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001135599.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
NM_003238.6
MANE Select
c.510+1311A>G
intron
N/ANP_003229.1
TGFB2
NM_001135599.4
c.594+1311A>G
intron
N/ANP_001129071.1
TGFB2
NR_138148.2
n.1876+1311A>G
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
ENST00000366930.9
TSL:1 MANE Select
c.510+1311A>G
intron
N/AENSP00000355897.4
TGFB2
ENST00000366929.4
TSL:1
c.594+1311A>G
intron
N/AENSP00000355896.4
TGFB2
ENST00000488793.1
TSL:3
n.174+1311A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.343
AC:
52119
AN:
151824
Hom.:
10477
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.494
Gnomad AMI
AF:
0.173
Gnomad AMR
AF:
0.443
Gnomad ASJ
AF:
0.309
Gnomad EAS
AF:
0.668
Gnomad SAS
AF:
0.380
Gnomad FIN
AF:
0.276
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.217
Gnomad OTH
AF:
0.351
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.344
AC:
52218
AN:
151942
Hom.:
10510
Cov.:
32
AF XY:
0.351
AC XY:
26041
AN XY:
74232
show subpopulations
African (AFR)
AF:
0.494
AC:
20460
AN:
41392
American (AMR)
AF:
0.444
AC:
6783
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.309
AC:
1072
AN:
3468
East Asian (EAS)
AF:
0.667
AC:
3448
AN:
5168
South Asian (SAS)
AF:
0.379
AC:
1826
AN:
4818
European-Finnish (FIN)
AF:
0.276
AC:
2908
AN:
10540
Middle Eastern (MID)
AF:
0.313
AC:
92
AN:
294
European-Non Finnish (NFE)
AF:
0.217
AC:
14723
AN:
67966
Other (OTH)
AF:
0.355
AC:
748
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1598
3196
4795
6393
7991
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
494
988
1482
1976
2470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.265
Hom.:
11714
Bravo
AF:
0.366
Asia WGS
AF:
0.482
AC:
1677
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
1.5
DANN
Benign
0.39
PhyloP100
-0.46
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1891467; hg19: chr1-218579985; COSMIC: COSV65108720; API